BAMBEVI
BAMBEVI
Approved
DIN Number
02520729
Drug Class
Human
Market Date
Nov 9, 2021
Company
HC
Apotex Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02520729
AIG Number0151381001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FG01 BEVACIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BEVACIZUMABActive
Strength: 100 MG / 4 ML
Monograph: BEVACIZUMAB